Abbott MediaRoom http://abbott.mediaroom.com/ North West London Pathology and Abbott Partner for Diagnostics Products and Services, including Alinity™, in Three NHS Trusts http://abbott.mediaroom.com/2017-08-15-North-West-London-Pathology-and-Abbott-Partner-for-Diagnostics-Products-and-Services-including-Alinity-TM-in-Three-NHS-Trusts Tue, 15 Aug 2017 08:00:00 -0400 http://abbott.mediaroom.com/2017-08-15-North-West-London-Pathology-and-Abbott-Partner-for-Diagnostics-Products-and-Services-including-Alinity-TM-in-Three-NHS-Trusts Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. http://abbott.mediaroom.com/2017-08-14-Abbott-Announces-Extension-of-Cash-Tender-Offer-for-All-Outstanding-Shares-of-Series-B-Convertible-Perpetual-Preferred-Stock-of-Alere-Inc Mon, 14 Aug 2017 08:00:00 -0400 http://abbott.mediaroom.com/2017-08-14-Abbott-Announces-Extension-of-Cash-Tender-Offer-for-All-Outstanding-Shares-of-Series-B-Convertible-Perpetual-Preferred-Stock-of-Alere-Inc The Cost of Malnutrition: Study Shows Nutrition Program Could Save Hospitals up to $3,800 per Patient http://abbott.mediaroom.com/2017-08-10-The-Cost-of-Malnutrition-Study-Shows-Nutrition-Program-Could-Save-Hospitals-up-to-3-800-per-Patient - 1 IN 3 PEOPLE ENTER A HOSPITAL MALNOURISHED OR AT-RISK OF MALNUTRITION(1-2) Thu, 10 Aug 2017 09:00:00 -0400 http://abbott.mediaroom.com/2017-08-10-The-Cost-of-Malnutrition-Study-Shows-Nutrition-Program-Could-Save-Hospitals-up-to-3-800-per-Patient Abbott Leads Way in First Clinical Trial of Minimally Invasive Clip-based Repair System for Leaky Tricuspid Heart Valves http://abbott.mediaroom.com/press-releases?item=124210 -Trial will study efficacy and safety of a new transcatheter clip-based repair system for tricuspid valve disease, an undertreated, life-altering condition Wed, 09 Aug 2017 08:37:00 -0400 http://abbott.mediaroom.com/press-releases?item=124210 Abbott Initiates Clinical Trial of Three-month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent http://abbott.mediaroom.com/press-releases?item=124209 - Trial will evaluate amount of time patients at high risk of bleeding should receive blood thinning medicine after treatment with XIENCE Tue, 25 Jul 2017 08:34:00 -0400 http://abbott.mediaroom.com/press-releases?item=124209